This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Liposome-mediated Gene Delivery in Precision Animal Breeding
BioVenic specializes in conducting research and laboratory-level R&D for the design of lipid nanoparticles. Through our versatile and scalable modular platform, we rapidly screen and optimize lipid particle formulations. Simultaneously, BioVenic focuses on optimizing payloads, targets, and delivery pathways to ensure the safe and reliable delivery of payloads to target tissues and efficient genome editing.
Introduction of Liposome-mediated Gene Delivery
Lipid-based delivery systems are considered to be very promising non-virus-mediated delivery methods for genome editing applications in precision animal breeding. Lipid nanoparticles (LNPs), which can be synthesized from a variety of lipid molecules, are superior gene delivery vehicles to traditional liposomes. The liposome-mediated gene delivery process uses LNPs as carriers to deliver payloads, such as CRISPR editing machinery, to target tissues and cells in vivo. This process not only protects the payload from degradation but also enhances its stability.
Fig.1 Schematic Diagram of Liposome-mediated Gene Delivery Process1,2.
Services for Liposome-mediated Gene Delivery
Why Choose Us?
Safe and effective liposomes that increase the chances of experimental success.
High-quality, scalable, customized liposome-mediated delivery solutions.
LNPs highly suitable for in vivo gene delivery in farmed animals.
Highly customized service supported by our technical experts throughout.
A one-stop solution including lipid design, optimization and manufacturing, allowing you to focus on payload development.
BioVenic is committed to developing tailor-made liposome-mediated gene delivery solutions for your scientific research projects. Our expert team has extensive experience and expertise in lipid development, protocol design, and package production. We are dedicated to meeting your specific needs for LNPs in scientific research projects focused on precision breeding. If you are seeking for liposome-mediated gene delivery solution, please contact us for more details about our services.
References
- Taha, Eman A., Joseph Lee, and Akitsu Hotta. "Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges." Journal of Controlled Release 342 (2022): 345-361.
- Image retrieved from Figure 4 "Schematic representation of the formulation and cellular entry mechanism of lipid nanoparticle (LNP)". Taha, Eman A.,et al., 2022, used under CC BY 4.0. The original image was modified by changing title to "Schematic Diagram of Liposome-mediated Gene Delivery Process".